Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma.

cancer stem cells hepatocellular carcinoma recurrence sonic hedgehog signaling pathway

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 09 11 2018
accepted: 06 08 2019
entrez: 16 10 2019
pubmed: 16 10 2019
medline: 16 10 2019
Statut: ppublish

Résumé

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-associated mortality worldwide. Hepatocarcinogenesis involves numerous interlinked factors and processes, including the Sonic hedgehog (Shh) signaling pathway, which participates in the carcinogenesis, progression, invasiveness, recurrence and cancer stem cell maintenance of HCC. The Shh signaling pathway is activated by ligands that bind to their receptor protein, Protein patched homolog (Ptch). The process of Shh ligand binding to Ptch weakens the inhibition of smoothened homolog (SMO) and activates signal transduction via glioma-associated oncogene homolog (Gli) transcription factors. The overexpression of Shh pathway molecules, including Shh, Ptch-1, Gli and SMO has been indicated in patients with HCC. It has also been suggested that the Shh signaling pathway exhibits cross-talk between numerous other signaling pathways. The inactivation of the Shh signaling pathway reduces HCC growth, increases radio-sensitivity and increases the beneficial effect of chemotherapy in HCC treatment. Therefore, inhibition of the Shh pathway may be an effective target therapy that can be used in the treatment of HCC.

Identifiants

pubmed: 31611946
doi: 10.3892/ol.2019.10826
pii: OL-0-0-10826
pmc: PMC6781692
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

4377-4384

Informations de copyright

Copyright: © Jeng et al.

Références

Onco Targets Ther. 2012;5:47-58
pubmed: 22500124
Cancer Res. 2012 Nov 15;72(22):5912-20
pubmed: 22986746
Cancer Res. 2014 Nov 1;74(21):5963-77
pubmed: 25189528
Oncogene. 2019 Mar;38(12):2206-2222
pubmed: 30470823
Cells. 2018 Aug 14;7(8):null
pubmed: 30110910
Cancer Res. 2018 Aug 1;78(15):4150-4162
pubmed: 29844124
Am J Pathol. 2018 Nov;188(11):2605-2616
pubmed: 30366594
World J Hepatol. 2019 Mar 27;11(3):261-272
pubmed: 30967904
Nature. 1996 Nov 14;384(6605):129-34
pubmed: 8906787
HPB (Oxford). 2013 Jan;15(1):31-9
pubmed: 23216777
Int J Mol Sci. 2019 Mar 18;20(6):null
pubmed: 30889843
J Gastrointestin Liver Dis. 2013 Sep;22(3):305-10
pubmed: 24078988
Hepatology. 2009 May;49(5 Suppl):S56-60
pubmed: 19399807
Oncogene. 2003 May 15;22(19):2972-83
pubmed: 12771949
PLoS One. 2018 Dec 4;13(12):e0208194
pubmed: 30513115
Acta Biochim Biophys Sin (Shanghai). 2008 Sep;40(9):819-29
pubmed: 18776995
Int J Mol Med. 2008 Sep;22(3):271-5
pubmed: 18698484
Am J Hum Genet. 2010 Dec 10;87(6):768-78
pubmed: 21129727
Oncogene. 2009 Oct 1;28(39):3468-76
pubmed: 19617900
Genes Dev. 2002 Nov 1;16(21):2743-8
pubmed: 12414725
Arch Toxicol. 2015 Feb;89(2):179-91
pubmed: 25559776
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Carcinogenesis. 2006 Apr;27(4):748-57
pubmed: 16339184
IET Syst Biol. 2013 Dec;7(6):243-51
pubmed: 24712101
Adv Exp Med Biol. 2015;815:113-30
pubmed: 25427904
Toxicol Appl Pharmacol. 2015 Oct 1;288(1):74-83
pubmed: 26189965
Cancer Res. 2011 Jan 15;71(2):435-44
pubmed: 21123452
J Dev Biol. 2016 Jul 20;4(3):23
pubmed: 27547735
World J Gastroenterol. 2014 Sep 7;20(33):11630-40
pubmed: 25206269
Hepatology. 2013 Sep;58(3):995-1010
pubmed: 23504944
Clin Cancer Res. 2010 Jun 15;16(12):3130-40
pubmed: 20530699
BMC Cancer. 2009 Jul 18;9:240
pubmed: 19615090
J Biol Chem. 2013 Apr 26;288(17):11786-94
pubmed: 23482563
Chin J Cancer Res. 2012 Dec;24(4):323-31
pubmed: 23359030
Tumour Biol. 2016 Oct 15;:null
pubmed: 27744627
Mol Cell Biol. 2017 Jan 19;37(3):
pubmed: 27849569
Cell Death Dis. 2014 Jan 02;5:e979
pubmed: 24384722
J Clin Invest. 2013 Jun;123(6):2380-94
pubmed: 23563311
Oncol Lett. 2012 Dec;4(6):1158-1162
pubmed: 23205113
Oncol Lett. 2016 Sep;12(3):1753-1762
pubmed: 27602109
J Biol Chem. 2010 Nov 19;285(47):36570-6
pubmed: 20858897
Hepatology. 2011 Nov;54(5):1580-90
pubmed: 21793033
Cancer Res. 2006 Feb 15;66(4):2081-8
pubmed: 16489008
Cancer Res. 2007 Apr 15;67(8):3583-93
pubmed: 17440069
Dev Cell. 2016 Aug 22;38(4):333-44
pubmed: 27554855
PLoS One. 2014 May 05;9(5):e95307
pubmed: 24798046
Lab Invest. 2010 Dec;90(12):1690-703
pubmed: 20697376
Annu Rev Physiol. 2015;77:105-29
pubmed: 25668018
Carcinogenesis. 2006 Jul;27(7):1334-40
pubmed: 16501253
Cell Res. 2011 Jan;21(1):159-68
pubmed: 21187858
Front Oncol. 2018 Sep 10;8:357
pubmed: 30250825
Int J Biochem Cell Biol. 2017 Aug;89:95-100
pubmed: 28600143
Oncogene. 2010 Apr 22;29(16):2309-24
pubmed: 20228847
Curr Mol Med. 2009 Sep;9(7):873-86
pubmed: 19860666
Int J Oncol. 2009 Mar;34(3):829-36
pubmed: 19212688
J Clin Transl Hepatol. 2018 Mar 28;6(1):69-78
pubmed: 29607307
Ann Surg Oncol. 2013 Feb;20(2):464-73
pubmed: 22911366
World J Surg Oncol. 2013 Jan 29;11:25
pubmed: 23356443
Am J Surg. 1999 Mar;177(3):209-15
pubmed: 10219856
Genetics. 1995 Jun;140(2):587-98
pubmed: 7498739
Genes Dev. 2008 Sep 15;22(18):2454-72
pubmed: 18794343
Bosn J Basic Med Sci. 2018 Feb 20;18(1):8-20
pubmed: 29274272
Nat Rev Cancer. 2013 Feb;13(2):123-35
pubmed: 23344543
Oncol Lett. 2015 Oct;10(4):2227-2232
pubmed: 26622824
Mol Cancer. 2016 Mar 18;15:24
pubmed: 26988232
Oncol Res. 2016;24(1):25-32
pubmed: 27178819
World J Gastroenterol. 2017 Jun 28;23(24):4330-4340
pubmed: 28706416
Mol Clin Oncol. 2016 Mar;4(3):369-374
pubmed: 26998285
Int J Mol Med. 2014 Sep;34(3):733-41
pubmed: 25017332
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):851-9
pubmed: 21377281
Genome Biol. 2008;9(11):241
pubmed: 19040769
Acta Pharmacol Sin. 2012 May;33(5):691-700
pubmed: 22543708
J Hepatol. 2018 Mar;68(3):550-562
pubmed: 29107151
Carcinogenesis. 2013 Jan;34(1):10-9
pubmed: 22948179
J Hepatol. 2016 Mar;64(3):618-27
pubmed: 26471504
J Biol Chem. 2001 Oct 19;276(42):38721-6
pubmed: 11514575
Cells. 2019 Feb 11;8(2):
pubmed: 30754706
Am J Surg. 2015 Sep;210(3):554-60
pubmed: 26073903
Cancer Lett. 2017 Sep 10;403:280-288
pubmed: 28652022
Gut Liver. 2016 May 23;10(3):332-9
pubmed: 27114433
Pharmacol Res. 2019 Mar;141:466-480
pubmed: 30639373
Cancer Res. 2011 Sep 1;71(17):5606-10
pubmed: 21862631
J Gastroenterol Hepatol. 2015 Aug;30(8):1317-24
pubmed: 25682950
Onco Targets Ther. 2013 Aug 05;6:1047-55
pubmed: 23950652
Can J Gastroenterol Hepatol. 2015 May;29(4):209-17
pubmed: 25965442
Cells. 2019 Apr 25;8(4):
pubmed: 31027259

Auteurs

Kuo-Shyang Jeng (KS)

Department of General Surgery, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan, R.O.C.
Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan, R.O.C.

Chi-Juei Jeng (CJ)

Graduate Institute of Clinical Medicine, National Taiwan University, Taipei City 10617, Taiwan, R.O.C.

Wen-Juei Jeng (WJ)

Department of Hepato-Gastroenterology, Chang-Gung Memorial Hospital, Linkou Medical Center, Chang-Gung University, Taoyuan City 33305, Taiwan, R.O.C.

I-Shyan Sheen (IS)

Graduate Institute of Clinical Medicine, National Taiwan University, Taipei City 10617, Taiwan, R.O.C.

Shih-Yun Li (SY)

Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan, R.O.C.

Chuen-Miin Leu (CM)

Institute of Microbiology and Immunology, National Yang-Ming University, Taipei City 11221, Taiwan, R.O.C.

Yeou-Guang Tsay (YG)

Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei City 11221, Taiwan, R.O.C.

Chiung-Fang Chang (CF)

Department of General Surgery, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan, R.O.C.
Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan, R.O.C.

Classifications MeSH